Zeynep Mine Coskun Yazici1, Bilgenur Bilge2, Sema Bolkent3. 1. Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Demiroglu Bilim University, Istanbul, Turkey. 2. Department of Medical Biology, Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, 34098, Cerrahpasa, Istanbul, Turkey. 3. Department of Medical Biology, Faculty of Cerrahpasa Medicine, Istanbul University-Cerrahpasa, 34098, Cerrahpasa, Istanbul, Turkey. bolkent@iuc.edu.tr.
Abstract
BACKGROUND: Hyperinsulinemia (HI) means that the amount of insulin in the blood is higher than normal and is often associated with type 2 diabetes. It is known that delta-9-tetrahydrocannabinol (THC) obtained from a medicinal plant, Cannabis sativa, has therapeutic effects on many diseases. OBJECTIVE: This study aimed to investigate the effects of THC on inflammatory and oxidant status in rat pancreas with HI. METHODS: Rats were divided into groups; Control, HI, THC and HI + THC. Each group consists of 8 animals. HI and HI + THC groups were given 10% fructose in the drinking water for 12 weeks. In the last four weeks of the experiment, 1.5 mg kg-1 THC was injected intraperitoneally daily into THC and HI + THC groups. The expression of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and nuclear factor-kappa B (NF-κB) were detected. JNK/SAPK and Grap2/p38 levels, total antioxidant and oxidant capacities (TAC and TOC) were analyzed in the pancreas. RESULTS: Levels of IL-6, NF-κβ, and TNF-α mRNA expression were higher in the pancreas with HI than in the control (p < 0.001 for all). THC treatment reduced the expression of IL-6, NF-κβ, and TNF-α mRNAs in the HI + THC group compared to the HI group (p < 0.001 for all). TOC increased in the HI group compared to the control group (p < 0.001). However, THC treatment reduced TOC levels in the HI + THC group compared to the HI group (p < 0.001). CONCLUSION: According to the results, the THC treatment may regulate inflammation and TOC in rats with hyperinsulinemia. Thus, we can say that THC may have anti-inflammatory and antioxidant potential in metabolic disorders.
BACKGROUND: Hyperinsulinemia (HI) means that the amount of insulin in the blood is higher than normal and is often associated with type 2 diabetes. It is known that delta-9-tetrahydrocannabinol (THC) obtained from a medicinal plant, Cannabis sativa, has therapeutic effects on many diseases. OBJECTIVE: This study aimed to investigate the effects of THC on inflammatory and oxidant status in rat pancreas with HI. METHODS: Rats were divided into groups; Control, HI, THC and HI + THC. Each group consists of 8 animals. HI and HI + THC groups were given 10% fructose in the drinking water for 12 weeks. In the last four weeks of the experiment, 1.5 mg kg-1 THC was injected intraperitoneally daily into THC and HI + THC groups. The expression of tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), and nuclear factor-kappa B (NF-κB) were detected. JNK/SAPK and Grap2/p38 levels, total antioxidant and oxidant capacities (TAC and TOC) were analyzed in the pancreas. RESULTS: Levels of IL-6, NF-κβ, and TNF-α mRNA expression were higher in the pancreas with HI than in the control (p < 0.001 for all). THC treatment reduced the expression of IL-6, NF-κβ, and TNF-α mRNAs in the HI + THC group compared to the HI group (p < 0.001 for all). TOC increased in the HI group compared to the control group (p < 0.001). However, THC treatment reduced TOC levels in the HI + THC group compared to the HI group (p < 0.001). CONCLUSION: According to the results, the THC treatment may regulate inflammation and TOC in rats with hyperinsulinemia. Thus, we can say that THC may have anti-inflammatory and antioxidant potential in metabolic disorders.
Authors: Benjamin E Young; Jaume Padilla; Stine H Finsen; Paul J Fadel; Stefan P Mortensen Journal: Endocrinology Date: 2022-03-01 Impact factor: 4.736
Authors: Anand P Gupta; Anees A Syed; Richa Garg; Umesh K Goand; Pragati Singh; Mohammed Riyazuddin; Guru R Valicherla; Athar Husain; Jiaur R Gayen Journal: Eur J Pharmacol Date: 2019-10-03 Impact factor: 4.432
Authors: Dana K Andersen; Murray Korc; Gloria M Petersen; Guido Eibl; Donghui Li; Michael R Rickels; Suresh T Chari; James L Abbruzzese Journal: Diabetes Date: 2017-05 Impact factor: 9.461
Authors: Alex S Yamashita; Thiago Belchior; Fábio S Lira; Nicolette C Bishop; Barbara Wessner; José C Rosa; William T Festuccia Journal: Mediators Inflamm Date: 2018-07-04 Impact factor: 4.711
Authors: Katharina S Weber; Marie-Christine Simon; Klaus Strassburger; Daniel F Markgraf; Anette E Buyken; Julia Szendroedi; Karsten Müssig; Michael Roden Journal: Nutrients Date: 2018-06-15 Impact factor: 5.717